Statin-related musculoskeletal pain in Parkinson's disease

Affiliations

Comment

Joseph Jankovic. Pain. 2017 Sep.

. 2017 Sep;158(9):1840.

doi: 10.1097/j.pain.0000000000000969.

No abstract available

Comment in

Reply.
Lien WC, Lien WH, Chiu CJ, Kuan TS. Lien WC, et al. Pain. 2017 Sep;158(9):1840-1841. doi: 10.1097/j.pain.0000000000000970. Pain. 2017. PMID: 28816888 No abstract available.

Parkinson disease and musculoskeletal pain: an 8-year population-based cohort study.
Lien WH, Lien WC, Kuan TS, Wu ST, Chen YT, Chiu CJ. Lien WH, et al. Pain. 2017 Jul;158(7):1234-1240. doi: 10.1097/j.pain.0000000000000904. Pain. 2017. PMID: 28328577

1. Antonini A, Tinazzi M. Targeting pain in Parkinson's disease. Lancet Neurol 2015;14:1144–5.
1. Bai S, Song Y, Huang X, Peng L, Jia J, Liu Y, Lu H. Statin use and the risk of Parkinson's disease: an updated meta-analysis. PLoS One 2016;11:e0152564.
1. Bykov K, Yoshida K, Weisskopf MG, Gagne JJ. Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 2017;26:294–300.
1. du Souich P, Roederer G, Dufour R. Myotoxicity of statins: mechanism of action. Pharmacol Ther 2017 Feb 14. pii: S0163-7258(17)30043-8.
1. Ha AD, Jankovic J. Pain in Parkinson's disease. Mov Disord 2012;27:485–91.